APOLLO HOSPITALS ENTER. L vs Jenburkt Pharmaceuticals Ltd

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and Jenburkt Pharmaceuticals Ltd (JENBURKTPHARMACEUTICALSLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

APOLLO HOSPITALS ENTER. L and Jenburkt Pharmaceuticals Ltd are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
14.00
13.42
P/B ratio
2.47
0.11%
Dividend yield
1.63%
₹135.04
EPS
₹72.64

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
20.40%
18.00%
Return on capital
27.00%
15.00%
EBITDA margin
27.00%
7.94%
Net margin
21.05%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
7.19%
33.39%
Profit CAGR (3Y)
10.66%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹484 Cr
₹25,228 Cr
Revenue
₹152 Cr
₹2,003 Cr
Net profit
₹32 Cr
0.90
Debt / equity
0.01
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Jenburkt Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 9.08% over past five years."]
APOLLO HOSPITALS ENTER. L full analysis Jenburkt Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLO HOSPITALS ENTER. L vs Jenburkt Pharmaceuticals Ltd: Share Price, Valuation & Which to Buy | DocStoX